AU Patent

AU2013328674B2 — Pyrrolobenzodiazepines and conjugates thereof

Assigned to MedImmune Ltd · Expires 2017-06-22 · 9y expired

What this patent protects

A compound which is selected from A, B and C, and salts and solvates thereof, as well as conjugates thereof with cell binding agents.

USPTO Abstract

A compound which is selected from A, B and C, and salts and solvates thereof, as well as conjugates thereof with cell binding agents.

Drugs covered by this patent

cobimetinib-fumarate (COBIMETINIB FUMARATE)

Patent Metadata

Patent number: AU2013328674B2
Jurisdiction: AU
Classification: —
Expires: 2017-06-22
Drug substance claim: No
Drug product claim: No
Assignee: MedImmune Ltd
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.